{"transactions":[{"id":893365,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Restricted Share Units","published_at":"2026-02-19T22:00:12.000Z","date":"2026-02-17","kind":"exercise","planned":false,"acquired":false,"shares":11824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one Ordinary Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On February 17, 2025, the Reporting Person was granted 47,297\nRSUs, vesting in four equal annual installments beginning February 17, 2026, subject to the Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On February 17, 2025, the Reporting Person was granted 47,297\nRSUs, vesting in four equal annual installments beginning February 17, 2026, subject to the Reporting Person's continuous service through each such vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Ordinary Shares may be represented by American Depositary Shares.  Each American Depositary Share represents one Ordinary Share."}],"balance_after":35473,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11824},"source":{"system":"sec-edgar","filing":"0001955244-26-000002","document":"form4-02192026_050203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524426000002/form4-02192026_050203.xml","form_type":"4"}},{"id":893364,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2026-02-19T22:00:12.000Z","date":"2026-02-18","kind":"sale","planned":false,"acquired":false,"shares":5965,"price":32.35,"value":192967.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Ordinary Shares may be represented by American Depositary Shares.  Each American Depositary Share represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.17 to $32.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5859,"source":{"system":"sec-edgar","filing":"0001955244-26-000002","document":"form4-02192026_050203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524426000002/form4-02192026_050203.xml","form_type":"4"}},{"id":893363,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2026-02-19T22:00:12.000Z","date":"2026-02-17","kind":"exercise","planned":false,"acquired":true,"shares":11824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Ordinary Shares may be represented by American Depositary Shares.  Each American Depositary Share represents one Ordinary Share."}],"balance_after":11824,"source":{"system":"sec-edgar","filing":"0001955244-26-000002","document":"form4-02192026_050203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524426000002/form4-02192026_050203.xml","form_type":"4"}},{"id":977619,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-12-08T21:15:14.000Z","date":"2025-12-05","kind":"exercise","planned":true,"acquired":false,"shares":572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":11832,"derivative":{"exercise_price":17.46,"expiration_date":"2028-09-12","underlying":"Ordinary Shares","underlying_shares":572},"source":{"system":"sec-edgar","filing":"0001955244-25-000015","document":"form4-12082025_041211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000015/form4-12082025_041211.xml","form_type":"4"}},{"id":977618,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-12-08T21:15:14.000Z","date":"2025-12-04","kind":"exercise","planned":true,"acquired":false,"shares":31341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":12404,"derivative":{"exercise_price":17.46,"expiration_date":"2028-09-12","underlying":"Ordinary Shares","underlying_shares":31341},"source":{"system":"sec-edgar","filing":"0001955244-25-000015","document":"form4-12082025_041211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000015/form4-12082025_041211.xml","form_type":"4"}},{"id":977617,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-12-08T21:15:14.000Z","date":"2025-12-05","kind":"sale","planned":true,"acquired":false,"shares":572,"price":40.14,"value":22960.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.21 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001955244-25-000015","document":"form4-12082025_041211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000015/form4-12082025_041211.xml","form_type":"4"}},{"id":977616,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-12-08T21:15:14.000Z","date":"2025-12-05","kind":"exercise","planned":true,"acquired":true,"shares":572,"price":17.46,"value":9987.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."}],"balance_after":572,"source":{"system":"sec-edgar","filing":"0001955244-25-000015","document":"form4-12082025_041211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000015/form4-12082025_041211.xml","form_type":"4"}},{"id":977615,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-12-08T21:15:14.000Z","date":"2025-12-04","kind":"sale","planned":true,"acquired":false,"shares":31341,"price":40.26,"value":1261788.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.02 to $40.44 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001955244-25-000015","document":"form4-12082025_041211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000015/form4-12082025_041211.xml","form_type":"4"}},{"id":977614,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-12-08T21:15:14.000Z","date":"2025-12-04","kind":"exercise","planned":true,"acquired":true,"shares":31341,"price":17.46,"value":547213.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."}],"balance_after":31341,"source":{"system":"sec-edgar","filing":"0001955244-25-000015","document":"form4-12082025_041211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000015/form4-12082025_041211.xml","form_type":"4"}},{"id":985082,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-12-01T21:10:05.000Z","date":"2025-11-28","kind":"exercise","planned":true,"acquired":false,"shares":5521,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":43745,"derivative":{"exercise_price":17.46,"expiration_date":"2028-09-12","underlying":"Ordinary Shares","underlying_shares":5521},"source":{"system":"sec-edgar","filing":"0001955244-25-000013","document":"form4-12012025_041201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000013/form4-12012025_041201.xml","form_type":"4"}},{"id":985081,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-12-01T21:10:05.000Z","date":"2025-11-26","kind":"exercise","planned":true,"acquired":false,"shares":69404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":49266,"derivative":{"exercise_price":17.46,"expiration_date":"2028-09-12","underlying":"Ordinary Shares","underlying_shares":69404},"source":{"system":"sec-edgar","filing":"0001955244-25-000013","document":"form4-12012025_041201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000013/form4-12012025_041201.xml","form_type":"4"}},{"id":985080,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-12-01T21:10:05.000Z","date":"2025-11-28","kind":"sale","planned":true,"acquired":false,"shares":5521,"price":40.09,"value":221336.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001955244-25-000013","document":"form4-12012025_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000013/form4-12012025_041201.xml","form_type":"4"}},{"id":985079,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-12-01T21:10:05.000Z","date":"2025-11-28","kind":"exercise","planned":true,"acquired":true,"shares":5521,"price":17.46,"value":96396.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."}],"balance_after":5521,"source":{"system":"sec-edgar","filing":"0001955244-25-000013","document":"form4-12012025_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000013/form4-12012025_041201.xml","form_type":"4"}},{"id":985078,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-12-01T21:10:05.000Z","date":"2025-11-26","kind":"sale","planned":true,"acquired":false,"shares":69404,"price":40.12,"value":2784488.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.40 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001955244-25-000013","document":"form4-12012025_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000013/form4-12012025_041201.xml","form_type":"4"}},{"id":985077,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-12-01T21:10:05.000Z","date":"2025-11-26","kind":"exercise","planned":true,"acquired":true,"shares":69404,"price":17.46,"value":1211793.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."}],"balance_after":69404,"source":{"system":"sec-edgar","filing":"0001955244-25-000013","document":"form4-12012025_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000013/form4-12012025_041201.xml","form_type":"4"}},{"id":986991,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-11-26T21:10:17.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":false,"shares":18020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":118670,"derivative":{"exercise_price":17.46,"expiration_date":"2028-09-12","underlying":"Ordinary Shares","underlying_shares":18020},"source":{"system":"sec-edgar","filing":"0001955244-25-000011","document":"form4-11262025_091110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000011/form4-11262025_091110.xml","form_type":"4"}},{"id":986990,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-11-26T21:10:17.000Z","date":"2025-11-24","kind":"exercise","planned":true,"acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":136690,"derivative":{"exercise_price":17.46,"expiration_date":"2028-09-12","underlying":"Ordinary Shares","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001955244-25-000011","document":"form4-11262025_091110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000011/form4-11262025_091110.xml","form_type":"4"}},{"id":986989,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-11-26T21:10:17.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":18020,"price":40.03,"value":721340.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001955244-25-000011","document":"form4-11262025_091110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000011/form4-11262025_091110.xml","form_type":"4"}},{"id":986988,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-11-26T21:10:17.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":true,"shares":18020,"price":17.46,"value":314629.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."}],"balance_after":18020,"source":{"system":"sec-edgar","filing":"0001955244-25-000011","document":"form4-11262025_091110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000011/form4-11262025_091110.xml","form_type":"4"}},{"id":986987,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-11-26T21:10:17.000Z","date":"2025-11-24","kind":"sale","planned":true,"acquired":false,"shares":100,"price":40,"value":4000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001955244-25-000011","document":"form4-11262025_091110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000011/form4-11262025_091110.xml","form_type":"4"}},{"id":986986,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-11-26T21:10:17.000Z","date":"2025-11-24","kind":"exercise","planned":true,"acquired":true,"shares":100,"price":17.46,"value":1746.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001955244-25-000011","document":"form4-11262025_091110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000011/form4-11262025_091110.xml","form_type":"4"}},{"id":1027237,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-10-02T20:10:05.000Z","date":"2025-09-30","kind":"exercise","planned":true,"acquired":false,"shares":61849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":136790,"derivative":{"exercise_price":17.46,"expiration_date":"2028-09-12","underlying":"Ordinary Shares","underlying_shares":61849},"source":{"system":"sec-edgar","filing":"0001955244-25-000008","document":"form4-10022025_041002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000008/form4-10022025_041002.xml","form_type":"4"}},{"id":1027236,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-10-02T20:10:05.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":61849,"price":35.23,"value":2178940.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.01 to $35.48 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001955244-25-000008","document":"form4-10022025_041002.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000008/form4-10022025_041002.xml","form_type":"4"}},{"id":1027235,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-10-02T20:10:05.000Z","date":"2025-09-30","kind":"exercise","planned":true,"acquired":true,"shares":61849,"price":17.46,"value":1079883.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."}],"balance_after":61849,"source":{"system":"sec-edgar","filing":"0001955244-25-000008","document":"form4-10022025_041002.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000008/form4-10022025_041002.xml","form_type":"4"}},{"id":1039349,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-09-16T20:15:10.000Z","date":"2025-09-15","kind":"exercise","planned":true,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately exercisable."}],"balance_after":198639,"derivative":{"exercise_price":17.46,"expiration_date":"2028-09-12","underlying":"Ordinary Shares","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001955244-25-000005","document":"form4-09162025_040906.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000005/form4-09162025_040906.xml","form_type":"4"}},{"id":1039348,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-09-16T20:15:10.000Z","date":"2025-09-12","kind":"exercise","planned":true,"acquired":false,"shares":22532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately exercisable."}],"balance_after":198839,"derivative":{"exercise_price":17.46,"expiration_date":"2028-09-12","underlying":"Ordinary Shares","underlying_shares":22532},"source":{"system":"sec-edgar","filing":"0001955244-25-000005","document":"form4-09162025_040906.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000005/form4-09162025_040906.xml","form_type":"4"}},{"id":1039347,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-09-16T20:15:10.000Z","date":"2025-09-15","kind":"sale","planned":true,"acquired":false,"shares":200,"price":35.01,"value":7002.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.01 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001955244-25-000005","document":"form4-09162025_040906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000005/form4-09162025_040906.xml","form_type":"4"}},{"id":1039346,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-09-16T20:15:10.000Z","date":"2025-09-15","kind":"exercise","planned":true,"acquired":true,"shares":200,"price":17.46,"value":3492.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0001955244-25-000005","document":"form4-09162025_040906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000005/form4-09162025_040906.xml","form_type":"4"}},{"id":1039345,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-09-16T20:15:10.000Z","date":"2025-09-12","kind":"sale","planned":true,"acquired":false,"shares":1300,"price":36.31,"value":47203.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.22 to $36.52 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001955244-25-000005","document":"form4-09162025_040906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000005/form4-09162025_040906.xml","form_type":"4"}},{"id":1039344,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-09-16T20:15:10.000Z","date":"2025-09-12","kind":"sale","planned":true,"acquired":false,"shares":21232,"price":35.63,"value":756496.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.22 to $36.21 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1300,"source":{"system":"sec-edgar","filing":"0001955244-25-000005","document":"form4-09162025_040906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000005/form4-09162025_040906.xml","form_type":"4"}},{"id":1039343,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-09-16T20:15:10.000Z","date":"2025-09-12","kind":"exercise","planned":true,"acquired":true,"shares":22532,"price":17.46,"value":393408.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."}],"balance_after":22532,"source":{"system":"sec-edgar","filing":"0001955244-25-000005","document":"form4-09162025_040906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000195524425000005/form4-09162025_040906.xml","form_type":"4"}},{"id":1041568,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-09-12T20:10:05.000Z","date":"2025-09-11","kind":"exercise","planned":true,"acquired":false,"shares":19081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately exercisable."}],"balance_after":221371,"derivative":{"exercise_price":17.46,"expiration_date":"2028-09-12","underlying":"Ordinary Shares","underlying_shares":19081},"source":{"system":"sec-edgar","filing":"0001415889-25-024359","document":"form4-09122025_040901.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588925024359/form4-09122025_040901.xml","form_type":"4"}},{"id":1041567,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-09-12T20:10:05.000Z","date":"2025-09-10","kind":"exercise","planned":true,"acquired":false,"shares":31338,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately exercisable."}],"balance_after":240452,"derivative":{"exercise_price":17.46,"expiration_date":"2028-09-12","underlying":"Ordinary Shares","underlying_shares":31338},"source":{"system":"sec-edgar","filing":"0001415889-25-024359","document":"form4-09122025_040901.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588925024359/form4-09122025_040901.xml","form_type":"4"}},{"id":1041566,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-09-12T20:10:05.000Z","date":"2025-09-11","kind":"sale","planned":true,"acquired":false,"shares":19081,"price":36.28,"value":692258.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.91 to $36.63 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-024359","document":"form4-09122025_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588925024359/form4-09122025_040901.xml","form_type":"4"}},{"id":1041565,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-09-12T20:10:05.000Z","date":"2025-09-11","kind":"exercise","planned":true,"acquired":true,"shares":19081,"price":17.46,"value":333154.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."}],"balance_after":19081,"source":{"system":"sec-edgar","filing":"0001415889-25-024359","document":"form4-09122025_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588925024359/form4-09122025_040901.xml","form_type":"4"}},{"id":1041564,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-09-12T20:10:05.000Z","date":"2025-09-10","kind":"sale","planned":true,"acquired":false,"shares":1200,"price":36.77,"value":44124.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.66 to $36.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-024359","document":"form4-09122025_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588925024359/form4-09122025_040901.xml","form_type":"4"}},{"id":1041563,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-09-12T20:10:05.000Z","date":"2025-09-10","kind":"sale","planned":true,"acquired":false,"shares":30138,"price":36.12,"value":1088584.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.66 to $36.65 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1200,"source":{"system":"sec-edgar","filing":"0001415889-25-024359","document":"form4-09122025_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588925024359/form4-09122025_040901.xml","form_type":"4"}},{"id":1041562,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2025-09-12T20:10:05.000Z","date":"2025-09-10","kind":"exercise","planned":true,"acquired":true,"shares":31338,"price":17.46,"value":547161.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025."}],"balance_after":31338,"source":{"system":"sec-edgar","filing":"0001415889-25-024359","document":"form4-09122025_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588925024359/form4-09122025_040901.xml","form_type":"4"}},{"id":1259962,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Restricted Share Units","published_at":"2025-02-19T21:18:07.000Z","date":"2025-02-17","kind":"grant","planned":false,"acquired":true,"shares":47297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit (\"RSU\") represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in four equal annual installments beginning February 17, 2026, subject to the Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in four equal annual installments beginning February 17, 2026, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":47297,"derivative":{"underlying":"Ordinary Shares","underlying_shares":47297},"source":{"system":"sec-edgar","filing":"0001415889-25-004605","document":"form4-02192025_090204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588925004605/form4-02192025_090204.xml","form_type":"4"}},{"id":1259961,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-02-19T21:18:07.000Z","date":"2025-02-17","kind":"grant","planned":false,"acquired":true,"shares":129518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option award shall vest on February 17, 2026, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":129518,"derivative":{"exercise_price":29.6,"expiration_date":"2035-02-16","underlying":"Ordinary Shares","underlying_shares":129518},"source":{"system":"sec-edgar","filing":"0001415889-25-004605","document":"form4-02192025_090204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588925004605/form4-02192025_090204.xml","form_type":"4"}},{"id":1607087,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2024-03-01T21:15:14.000Z","date":"2024-02-28","kind":"exercise","planned":true,"acquired":false,"shares":36509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Immediately exercisable."}],"balance_after":271790,"derivative":{"exercise_price":17.46,"expiration_date":"2028-09-12","underlying":"Ordinary Shares","underlying_shares":36509},"source":{"system":"sec-edgar","filing":"0001415889-24-006079","document":"form4-03012024_040305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588924006079/form4-03012024_040305.xml","form_type":"4"}},{"id":1607086,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2024-03-01T21:15:14.000Z","date":"2024-02-28","kind":"sale","planned":true,"acquired":false,"shares":1200,"price":70.45,"value":84540.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.42 to $70.48 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-006079","document":"form4-03012024_040305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588924006079/form4-03012024_040305.xml","form_type":"4"}},{"id":1607085,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2024-03-01T21:15:14.000Z","date":"2024-02-28","kind":"sale","planned":true,"acquired":false,"shares":10937,"price":69.73,"value":762637.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.26 to $70.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1200,"source":{"system":"sec-edgar","filing":"0001415889-24-006079","document":"form4-03012024_040305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588924006079/form4-03012024_040305.xml","form_type":"4"}},{"id":1607084,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2024-03-01T21:15:14.000Z","date":"2024-02-28","kind":"sale","planned":true,"acquired":false,"shares":7472,"price":68.84,"value":514372.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.26 to $69.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":12137,"source":{"system":"sec-edgar","filing":"0001415889-24-006079","document":"form4-03012024_040305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588924006079/form4-03012024_040305.xml","form_type":"4"}},{"id":1607083,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2024-03-01T21:15:14.000Z","date":"2024-02-28","kind":"sale","planned":true,"acquired":false,"shares":16900,"price":67.61,"value":1142609.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.08 to $68.06 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":19609,"source":{"system":"sec-edgar","filing":"0001415889-24-006079","document":"form4-03012024_040305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588924006079/form4-03012024_040305.xml","form_type":"4"}},{"id":1607082,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2024-03-01T21:15:14.000Z","date":"2024-02-28","kind":"exercise","planned":true,"acquired":true,"shares":36509,"price":17.46,"value":637447.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023."}],"balance_after":36509,"source":{"system":"sec-edgar","filing":"0001415889-24-006079","document":"form4-03012024_040305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588924006079/form4-03012024_040305.xml","form_type":"4"}},{"id":1612325,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2024-02-28T21:15:31.000Z","date":"2024-02-27","kind":"exercise","planned":true,"acquired":false,"shares":54938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Immediately exercisable."}],"balance_after":308299,"derivative":{"exercise_price":17.46,"expiration_date":"2028-09-12","underlying":"Ordinary Shares","underlying_shares":54938},"source":{"system":"sec-edgar","filing":"0001415889-24-005720","document":"form4-02282024_040201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588924005720/form4-02282024_040201.xml","form_type":"4"}},{"id":1612324,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2024-02-28T21:15:31.000Z","date":"2024-02-26","kind":"exercise","planned":true,"acquired":false,"shares":28553,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Immediately exercisable."}],"balance_after":363237,"derivative":{"exercise_price":17.46,"expiration_date":"2028-09-12","underlying":"Ordinary Shares","underlying_shares":28553},"source":{"system":"sec-edgar","filing":"0001415889-24-005720","document":"form4-02282024_040201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588924005720/form4-02282024_040201.xml","form_type":"4"}},{"id":1612323,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2024-02-28T21:15:31.000Z","date":"2024-02-27","kind":"sale","planned":true,"acquired":false,"shares":3394,"price":71.97,"value":244266.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.85 to $72.28 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-005720","document":"form4-02282024_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588924005720/form4-02282024_040201.xml","form_type":"4"}},{"id":1612322,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2024-02-28T21:15:31.000Z","date":"2024-02-27","kind":"sale","planned":true,"acquired":false,"shares":25944,"price":71.32,"value":1850326.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.84 to $71.8307 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3394,"source":{"system":"sec-edgar","filing":"0001415889-24-005720","document":"form4-02282024_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588924005720/form4-02282024_040201.xml","form_type":"4"}},{"id":1612321,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2024-02-28T21:15:31.000Z","date":"2024-02-27","kind":"sale","planned":true,"acquired":false,"shares":21152,"price":70.42,"value":1489523.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.835 to $70.8248 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":29338,"source":{"system":"sec-edgar","filing":"0001415889-24-005720","document":"form4-02282024_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588924005720/form4-02282024_040201.xml","form_type":"4"}},{"id":1612320,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2024-02-28T21:15:31.000Z","date":"2024-02-27","kind":"sale","planned":true,"acquired":false,"shares":4448,"price":69.45,"value":308913.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.835 to $69.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":50490,"source":{"system":"sec-edgar","filing":"0001415889-24-005720","document":"form4-02282024_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588924005720/form4-02282024_040201.xml","form_type":"4"}},{"id":1612319,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2024-02-28T21:15:31.000Z","date":"2024-02-27","kind":"exercise","planned":true,"acquired":true,"shares":54938,"price":17.46,"value":959217.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023."}],"balance_after":54938,"source":{"system":"sec-edgar","filing":"0001415889-24-005720","document":"form4-02282024_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588924005720/form4-02282024_040201.xml","form_type":"4"}},{"id":1612318,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2024-02-28T21:15:31.000Z","date":"2024-02-26","kind":"sale","planned":true,"acquired":false,"shares":2037,"price":71.31,"value":145258.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.09 to $71.685 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-005720","document":"form4-02282024_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588924005720/form4-02282024_040201.xml","form_type":"4"}},{"id":1612317,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2024-02-28T21:15:31.000Z","date":"2024-02-26","kind":"sale","planned":true,"acquired":false,"shares":26516,"price":70.6,"value":1872029.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.09 to $71.088 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2037,"source":{"system":"sec-edgar","filing":"0001415889-24-005720","document":"form4-02282024_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588924005720/form4-02282024_040201.xml","form_type":"4"}},{"id":1612316,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Ordinary Shares","published_at":"2024-02-28T21:15:31.000Z","date":"2024-02-26","kind":"exercise","planned":true,"acquired":true,"shares":28553,"price":17.46,"value":498535.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023."}],"balance_after":28553,"source":{"system":"sec-edgar","filing":"0001415889-24-005720","document":"form4-02282024_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588924005720/form4-02282024_040201.xml","form_type":"4"}},{"id":1629286,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65663,"kind":"person","name":"Berman David M","position":1,"cik":"0001955244","reported_name":"Berman David M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2024-02-21T21:15:38.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":111244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option award shall vest on February 16, 2025, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":111244,"derivative":{"exercise_price":70.5,"expiration_date":"2034-02-15","underlying":"Ordinary Shares","underlying_shares":111244},"source":{"system":"sec-edgar","filing":"0001415889-24-004591","document":"form4-02212024_040222.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588924004591/form4-02212024_040222.xml","form_type":"4"}}]}